Latest news
NECTIN-4 Expression Changes and Resistance After EV/Pembro in Metastatic Urothelial Carcinoma - David Aggen - UroTodayUroToday · Tue, 04 Aug 2026 20:50:47 GMTAptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTAptevo Filing May Support Radiopharmaceuticals and T-Cell Engagers - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT